[Overview of Animal Researches About the Effects of Systemic Drugs on Implant Osseointegration]
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Implant osseointegration is an important biological basis for dental implantology. Many factors, including surgical factors, implant factors, and patients' own factors, affect implant osseointegration. Notably, the application of systemic drugs to improve implant osseointegration has become a research hotspot. This article reviews the effects of systemic drugs on implant osseointegration based on animal researches to provide systemic drug selection to improve implant osseointegration and lay a good foundation for later clinical trials.
References
1.
Karlsson J, Martinelli A, Fathali H, Bielecki J, Andersson M
. The effect of alendronate on biomineralization at the bone/implant interface. J Biomed Mater Res A. 2015; 104(3):620-629.
DOI: 10.1002/jbm.a.35602.
View
2.
Neer R, Arnaud C, Zanchetta J, Prince R, Gaich G, Reginster J
. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344(19):1434-41.
DOI: 10.1056/NEJM200105103441904.
View
3.
Kurth A, Eberhardt C, Muller S, Steinacker M, Schwarz M, Bauss F
. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats. Bone. 2005; 37(2):204-10.
DOI: 10.1016/j.bone.2004.12.017.
View
4.
Zhou C, Li Y, Wang X, Shui X, Hu J
. 1,25Dihydroxy vitamin D(3) improves titanium implant osseointegration in osteoporotic rats. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 114(5 Suppl):S174-8.
DOI: 10.1016/j.oooo.2011.09.030.
View
5.
Faverani L, Polo T, Ramalho-Ferreira G, Momesso G, Hassumi J, Rossi A
. Raloxifene but not alendronate can compensate the impaired osseointegration in osteoporotic rats. Clin Oral Investig. 2017; 22(1):255-265.
DOI: 10.1007/s00784-017-2106-2.
View